These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17060567)

  • 1. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
    Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.
    Pritchett YL; McCarberg BH; Watkin JG; Robinson MJ
    Pain Med; 2007; 8(5):397-409. PubMed ID: 17661853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
    Kajdasz DK; Iyengar S; Desaiah D; Backonja MM; Farrar JT; Fishbain DA; Jensen TS; Rowbotham MC; Sang CN; Ziegler D; McQuay HJ
    Clin Ther; 2007; 29 Suppl():2536-46. PubMed ID: 18164920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
    Raskin J; Pritchett YL; Wang F; D'Souza DN; Waninger AL; Iyengar S; Wernicke JF
    Pain Med; 2005; 6(5):346-56. PubMed ID: 16266355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
    Raskin J; Wang F; Pritchett YL; Goldstein DJ
    Pain Med; 2006; 7(5):373-85. PubMed ID: 17014595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
    Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
    Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.
    Armstrong DG; Chappell AS; Le TK; Kajdasz DK; Backonja M; D'Souza DN; Russell JM
    Pain Med; 2007; 8(5):410-8. PubMed ID: 17661854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
    Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
    Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
    Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
    JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Skljarevski V; Desaiah D; Zhang Q; Chappell AS; Detke MJ; Gross JL; Ziegler D
    Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
    Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
    Wasan AD; Ossanna MJ; Raskin J; Wernicke JF; Robinson MJ; Hall JA; Edwards SE; Lipsius S; Meyers AL; McCarberg BH
    Curr Drug Saf; 2009 Jan; 4(1):22-9. PubMed ID: 19149522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
    J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
    Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
    J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine: a review of its pharmacology and use in chronic pain management.
    Bellingham GA; Peng PW
    Reg Anesth Pain Med; 2010; 35(3):294-303. PubMed ID: 20921842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
    Wernicke JF; Prakash A; Kajdasz DK; Houston J
    J Diabetes Complications; 2009; 23(5):349-59. PubMed ID: 18768332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
    Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
    Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.